Company intelligence / Profile preview
Procaps Group
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Other
Overview
Procaps Group operates at commercial scale with a broad portfolio of over-the-counter pharmaceuticals, prescription drugs, nutritional supplements, and clinical solutions distributed in more than 50 countries. The company has recently undergone significant restructuring and secured $130 million in new equity investment to support growth and operational turnaround under new strategic leadership.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologicNutritional supplementSoftgel-based drug delivery
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Procaps Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Procaps Group.